Tanzania's pharmaceutical market is among the largest in Sub-Saharan Africa. In 2017, Tanzania's pharmaceutical market was valued at TZS1.11trn (USD496mn), or 1.0% of GDP, with per-capita drug expenditure at just under USD9. This is fairly modest in global terms and even by regional standards. Due to low purchasing power, generic drugs comprise the majority of Tanzania's pharmaceuticals market, providing opportunities for companies focused on off-patent drugs. Patented drugs only hold a small market share as low per-capita drug expenditure continues to limit the capacity of most of the population to purchase higher-priced medication. Self-medication is prevalent in Tanzania, making the OTC medicine market an attractive prospect. Pharmaceutical sales accounted 26% of health expenditure.

Key View

SWOT

Industry Forecast

Pharmaceutical Market Forecast 

Healthcare Market Forecast

Pharmaceutical Trade Forecast 

Industry Risk/Reward Index

Sub-Saharan Africa Innovative Pharmaceuticals Risk/Reward Index 

Tanzania Innovative Pharmaceuticals Risk/Reward Index 

Regulatory Development

Regulatory Overview 

Market Overview

Competitive Landscape

Tanzania Demographic Outlook 

Pharmaceuticals & Healthcare Glossary 

Pharmaceuticals & Healthcare Methodology